ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Hematology Oncology

Top Hematology Oncology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ZAHID DAR MD

Hematology Oncology

1,275

$575K

160
133 are 65+

11%
patients receiving schedule two controlled substances

Avg: 13%

14%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 15%

$451
Average prescription price

Avg: $356

DANIEL BURNS MD

Hematology Oncology

1,274

$481K

166
145 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 15%

$377
Average prescription price

Avg: $356

MUHAMMAD MUSLIM MD

Hematology Oncology

1,268

$495K

141
95 are 65+

28%
patients receiving schedule two controlled substances

Avg: 13%

18%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 15%

$391
Average prescription price

Avg: $356

BILAL NAQVI MD

Hematology Oncology

1,232

$154K

131
96 are 65+

24%
patients receiving schedule two controlled substances

Avg: 13%

18%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$125
Average prescription price

Avg: $356

RUBINA QAMAR MD

Hematology Oncology

1,227

$472K

187
155 are 65+

7%
patients receiving schedule two controlled substances

Avg: 13%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 15%

$385
Average prescription price

Avg: $356

PAULA GILL MD

Hematology Oncology

1,173

$303K

143
109 are 65+

13%
patients receiving schedule two controlled substances

Avg: 13%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 15%

$258
Average prescription price

Avg: $356

ANTHONY PHILLIPS M.D.

Hematology Oncology

1,143

$585K

201
165 are 65+

9%
patients receiving schedule two controlled substances

Avg: 13%

12%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 15%

$512
Average prescription price

Avg: $356

COREY SHAMAH M.D.

Hematology Oncology

1,140

$794K

142
122 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 15%

$696
Average prescription price

Avg: $356

ADEDAYO ONITILO MD

Hematology Oncology

1,132

$189K

208
174 are 65+

9%
patients receiving schedule two controlled substances

Avg: 13%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$167
Average prescription price

Avg: $356

BRENDA PIERCE MD

Hematology Oncology

1,129

$336K

181
154 are 65+

10%
patients receiving schedule two controlled substances

Avg: 13%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 15%

$298
Average prescription price

Avg: $356

MICHAEL MULLANE MD

Hematology Oncology

1,127

$341K

181
157 are 65+

11%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 15%

$302
Average prescription price

Avg: $356

JOEL LUNDBERG MD

Hematology Oncology

1,110

$697K

176
150 are 65+

10%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 15%

$628
Average prescription price

Avg: $356

GILBERTO RODRIGUES M.D.

Hematology Oncology

1,099

$473K

147
133 are 65+

17%
patients receiving schedule two controlled substances

Avg: 13%

12%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 15%

$431
Average prescription price

Avg: $356

JOSHUA FIELD MD

Hematology Oncology

1,023

$476K

60
0 are 65+

83%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 15%

$465
Average prescription price

Avg: $356

DOUGLAS REDING MD

Hematology Oncology

976

$193K

149
125 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

21%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 15%

$197
Average prescription price

Avg: $356

JOHN FARNEN MD

Hematology Oncology

964

$288K

109
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 15%

$299
Average prescription price

Avg: $356

RICHARD HANSEN MD

Hematology Oncology

958

$153K

123
108 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$160
Average prescription price

Avg: $356

JERRY WINKLER M.D.

Hematology Oncology

956

$255K

165
127 are 65+

17%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$267
Average prescription price

Avg: $356

AVI BAR-LEV M.D.

Hematology Oncology

951

$541K

157
138 are 65+

18%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 15%

$569
Average prescription price

Avg: $356

CHRISTOPHER HAKE MD

Hematology Oncology

945

$328K

131
114 are 65+

17%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 15%

$347
Average prescription price

Avg: $356

JEAN PELISKA M.D.

Hematology Oncology

940

$356K

156
142 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$378
Average prescription price

Avg: $356

LAURA MCGARTLAND M.D.

Hematology Oncology

930

$457K

147
116 are 65+

16%
patients receiving schedule two controlled substances

Avg: 13%

14%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 15%

$492
Average prescription price

Avg: $356

ANTONY RUGGERI M.D.

Hematology Oncology

907

$434K

150
121 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$478
Average prescription price

Avg: $356

PATCHARIN TANAWATTANACHAROEN MD

Hematology Oncology

903

$90.1K

109
76 are 65+

23%
patients receiving schedule two controlled substances

Avg: 13%

14%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$100
Average prescription price

Avg: $356

CHERUPPOLIL SANTHOSH-KUMAR MD

Hematology Oncology

855

$586K

153
137 are 65+

18%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 15%

$686
Average prescription price

Avg: $356

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank